The global single-use bronchoscopes market size was valued at USD 464.34 million in 2025 and is projected to grow from USD 504.69 million in 2026 to USD 982.97 million by 2034, registering a CAGR of 8.69% during the forecast period (2026–2034). North America dominated the single-use bronchoscopes market with a market share of 40.57% in 2025.
Single-use bronchoscopes are sterile, disposable endoscopic devices used to examine and treat the airways and lungs without the need for reprocessing after use. They help minimize the risk of contamination and hospital-acquired infections while ensuring immediate availability in critical care settings.
The single-use bronchoscopes market demand is driven by the rising prevalence of respiratory diseases, growing preference for infection prevention, and increasing number of bronchoscopy procedures. Healthcare providers are adopting disposable bronchoscopes to improve patient safety and enhance workflow efficiency. Continuous technological advancements and increasing awareness regarding infection control are further contributing to single-use bronchoscopes market growth.
Download a Free Sample To learn more about this report,
Expansion of Single-Use Bronchoscopes for Robotic-Assisted Peripheral Lung Navigation
Single-use bronchoscopes are increasingly being engineered for compatibility with robotic bronchoscopy platforms targeting peripheral pulmonary nodules. Their sterile design eliminates contamination risks during high-precision navigation while ensuring immediate procedural readiness. Olympus expanded evidence supporting compatibility of disposable bronchoscopy accessories with robotic-assisted peripheral lung biopsy workflows, reflecting growing clinical adoption of minimally invasive lung cancer diagnostic pathways across advanced respiratory centers.
Integration of Disposable Bronchoscopes into ICU Airway Response Protocols
Hospitals are increasingly embedding single-use bronchoscopes into standardized intensive care airway response protocols instead of maintaining centralized reusable bronchoscope inventories. Dedicated disposable bronchoscope placement within ICUs enables immediate bedside intubation support, secretion management, and tracheostomy guidance while eliminating reprocessing delays. This decentralized deployment model is reshaping procurement strategies, emphasizing procedure readiness, infection prevention, and uninterrupted critical-care respiratory interventions.
The single-use bronchoscopes market is highly exposed to supply chain disruptions because it depends on globally sourced CMOS imaging sensors, LED light sources, medical-grade polymers, sterile packaging materials, electronic components, and precision-molded disposable assemblies that must comply with stringent regulatory and quality standards. Disruptions in component availability increase manufacturing lead times, delay product deliveries to healthcare facilities, and raise production costs, affecting the timely availability of single-use bronchoscopes for diagnostic and therapeutic respiratory procedures worldwide. The market is expected to experience a capacity-constrained recovery, as manufacturers are regionalizing production, diversifying supplier networks, increasing strategic inventories, and strengthening supply chain visibility to improve resilience and reduce dependence on single-source suppliers.
Rising Hospital Focus on Infection Prevention and Growing Adoption of Bedside Bronchoscopy in ICUs Drives Market
The growing emphasis on hospital-acquired infection prevention is increasing demand for single-use bronchoscopes by eliminating risks associated with reusable endoscope reprocessing and potential cross-contamination. Healthcare facilities are strengthening infection-control protocols and prioritizing sterile devices for critical respiratory procedures. This shift encourages broader procurement of single use bronchoscopes, strengthens hospital purchasing decisions, and drives market growth through wider clinical adoption across emergency, critical care, and operating room settings.
The increasing use of bedside bronchoscopy in intensive care units is creating strong demand for portable single-use bronchoscopes providing immediate airway visualization without centralized endoscopy resources. Critically ill patients require urgent bronchoscopic interventions for secretion clearance, difficult intubation, tracheostomy guidance, and airway assessment. For example, Ambu's aScope 5 Broncho enables rapid bedside deployment, supporting faster clinical decisions. Hospitals increasingly invest in these systems, accelerating growth.
High Per-Procedure Cost and Limited Availability of Advanced Imaging Performance Restrain Market Expansion
Single-use bronchoscopes require a new sterile device for every procedure, increasing per-procedure costs compared with reusable systems in high-volume hospitals. According to the National Center for Biotechnology Research, single-use bronchoscope costs are USD 300–400 per procedure, while reusable bronchoscopes averaged USD 198–202 in high-volume endoscopy units. This cost difference encourages many hospitals to retain reusable systems, limiting broader adoption of single-use bronchoscopes despite their infection-control advantages.
Although imaging quality continues to improve, some single-use bronchoscopes offer lower optical performance and fewer advanced functionalities than premium reusable video bronchoscopes during complex interventional procedures. Pulmonologists performing advanced airway interventions may therefore continue relying on reusable systems for challenging cases. This performance gap restricts the replacement of reusable bronchoscopes across specialized respiratory centers, limiting overall market expansion.
Growth of AI-Based Bronchoscopy Image Archiving Platforms and Increasing Demand in Clinical Simulation Offer Growth Opportunities to Market Players
The increasing adoption of cloud-connected bronchoscopy image management platforms creates a growth opportunity for manufacturers offering single use bronchoscopes with integrated digital documentation capabilities. Hospitals are seeking seamless transfer of bronchoscopy images into electronic medical records to improve workflow and clinical reporting. Companies such as Ambu with Ambu aView 2 Advance and Olympus are expanding digital visualization ecosystems, creating future opportunities for software-enabled disposable bronchoscopy solutions.
Medical schools, simulation centers, and teaching hospitals are increasingly adopting single use bronchoscopes for bronchoscopy training because they eliminate reprocessing requirements, simplify logistics, and ensure consistent device availability without affecting clinical inventories. This creates a new customer segment beyond routine patient care, enabling manufacturers to expand into medical education. As simulation-based respiratory training continues to grow globally, demand for dedicated disposable training bronchoscopes is expected to increase steadily, creating long-term commercial opportunities.
Clinical Preference for Reusable Bronchoscopes and Managing Electronic Waste Challenges Market Growth
Many interventional pulmonologists continue to rely on reusable therapeutic bronchoscopes for complex procedures requiring larger working channels, superior maneuverability, and compatibility with advanced accessories. For example, endobronchial ultrasound-guided biopsies and bronchial tumor debulking are still predominantly performed using reusable bronchoscopes. This dependence limits replacement rates of disposable devices and slows the penetration of single-use bronchoscopes in tertiary respiratory and interventional pulmonary centers.
The increasing use of single-use bronchoscopes generates substantial electronic and plastic medical waste, creating environmental and disposal challenges for healthcare providers. These devices contain electronic imaging components, batteries, and medical-grade polymers that require specialized waste handling after use. As hospitals strengthen sustainability initiatives and governments tighten medical waste regulations, manufacturers face increasing pressure to develop environmentally responsible designs and recycling solutions while maintaining product safety and regulatory compliance.
The ICUs segment accounted for a share of 38.95% in 2025, owing to the frequent requirement for bedside bronchoscopy in mechanically ventilated patients, immediate airway secretion management, and difficult intubation support. Continuous device availability without reprocessing delays further strengthens disposable bronchoscope adoption across critical care environments.
The emergency rooms segment is expected to grow at a CAGR of 9.14% during the forecast period, driven by the increasing emergency airway interventions, rising trauma-related respiratory emergencies, and demand for immediately available sterile bronchoscopes. Disposable devices support rapid clinical response while eliminating delays associated with reusable scope preparation and disinfection.
Request Customizationto receive a tailored report.
In 2025, lung cancer accounted for a share of 29.20% due to increasing bronchoscopic biopsy procedures, expanding early pulmonary nodule evaluation, and greater use of minimally invasive diagnostic pathways. Disposable bronchoscopes also reduce contamination concerns during repeated diagnostic interventions across oncology centers.
The COPD segment is expected to grow at a CAGR of 9.48% during the forecast period, fueled by rising hospital admissions for acute exacerbations requiring bronchoscopic airway clearance and secretion management. Growing use of bedside bronchoscopy for critically ill COPD patients further accelerates demand for sterile disposable bronchoscopes.
The hospital segment is expected to grow at a CAGR of 9.33% due to multidisciplinary bronchoscopy services across pulmonology, critical care, anesthesia, and thoracic surgery departments, creating consistently high procedure volumes. Centralized procurement programs and emergency care further accelerate adoption of single-use bronchoscopes throughout hospital networks.
The outpatient facilities segment is expected to grow at a CAGR of 9.72% during the forecast period, driven by increasing emphasis on same-day respiratory diagnostics, lean clinical operations, and lower capital equipment requirements. Disposable bronchoscopes enable outpatient centers to perform bronchoscopy without investing in dedicated reprocessing units, improving operational efficiency and patient throughput.
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by Strong Infection Prevention Practices and Rising Adoption of Minimally Invasive Pulmonary Procedures
The North America single-use bronchoscopes market accounted for the largest regional share of 40.57% in 2025, driven by infection prevention protocols, widespread adoption of disposable endoscopy technologies, and high bronchoscopy procedure volumes across intensive care units, operating rooms, and emergency departments. The region also benefits from advanced healthcare infrastructure, favorable reimbursement for respiratory procedures, and strong regulatory support for innovative medical devices.
The United States single-use bronchoscopes market was valued at USD 162.89 million in 2025, driven by increasing demand for infection-control solutions, growing use of bedside bronchoscopy in critical care, and rising adoption of minimally invasive pulmonary procedures. Healthcare providers are increasingly investing in disposable bronchoscopy technologies to reduce cross-contamination risks, eliminate reprocessing requirements, and improve procedural efficiency.
The single-use bronchoscopes market in Canada was valued at USD 25.49 million in 2025, supported by expansion of respiratory care services and modernization of bronchoscopy practices. The country's publicly funded healthcare system and growing investments in critical care infrastructure continue to create favorable conditions for the adoption of single-use bronchoscopy technologies across major healthcare institutions.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Fastest Growth Driven by Expansion of Respiratory Endoscopy Capacity and Local Manufacturing of Disposable Bronchoscopes
The Asia Pacific single-use bronchoscopes market is expected to grow at a CAGR of 10.16% during the forecast period, showcasing the fastest regional growth. Growth is supported by expanding respiratory endoscopy services, increasing localization of disposable bronchoscope manufacturing, and rising adoption of infection control technologies across developing healthcare systems.
The China single-use bronchoscopes market was valued at USD 25.12 million in 2025, supported by rapid commercialization of domestically developed disposable bronchoscopes and expansion of local medical device manufacturing capabilities. Domestic manufacturers are improving product affordability and accelerating penetration into county-level hospitals, while national procurement initiatives are increasing accessibility of advanced bronchoscopy technologies across provincial healthcare systems.
The India single-use bronchoscopes market was valued at USD 13.28 million in 2025, fueled by increasing expansion of pulmonary medicine departments in private multispecialty hospitals and growing demand for infection-safe bronchoscopy in intensive care. The country is also witnessing greater adoption of disposable bronchoscopes by hospitals seeking to reduce dependence on limited endoscope reprocessing infrastructure while improving respiratory procedure turnaround times.
The Japan single-use bronchoscopes market was valued at USD 15.32 million in 2025, supported by strong preference for high-quality minimally invasive respiratory technologies and increasing bronchoscopy demand within its aging population. In February 2026, Olympus America received US FDA clearance for pediatric use of two H-SteriScope single-use bronchoscopes manufactured by Hunan Vathin Medical, highlighting continued innovation in disposable bronchoscopy technologies originating from Japanese industry expertise and strengthening confidence in advanced single-use respiratory devices.
The single-use bronchoscopes market competitive landscape is moderately consolidated, with competition led by established endoscopy and airway management companies alongside specialized disposable endoscope manufacturers. Leading players compete through innovations in imaging quality, suction performance, ergonomic design, infection prevention, and compatibility with digital visualization platforms while expanding their global distribution networks. The single-use bronchoscopes market ecosystem is shaped by stringent infection-control standards, increasing adoption of minimally invasive respiratory procedures, and evolving hospital procurement strategies.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Automated External Defibrillators Market Size, Share, Growth, 2034
Kyphoplasty Market Size, Share, Growth, Analysis, Report, 2034
Aerosol Delivery Devices Market Size, Share, Growth, 2034
Defibrillator Market Size, Share, Growth, Analysis, Report, 2034
Colorectal Cancer Screening Market Size, Share, Growth, 2034
Medical Implants Market Size, Share, Growth, Forecast, 2034
We are featured on:
sales@straitsresearch.com